AT363491B - Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen - Google Patents

Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen

Info

Publication number
AT363491B
AT363491B AT0714478A AT714478A AT363491B AT 363491 B AT363491 B AT 363491B AT 0714478 A AT0714478 A AT 0714478A AT 714478 A AT714478 A AT 714478A AT 363491 B AT363491 B AT 363491B
Authority
AT
Austria
Prior art keywords
xanthins
salts
producing new
producing
new
Prior art date
Application number
AT0714478A
Other languages
English (en)
Other versions
ATA714478A (de
Inventor
Sten Hakan Axel Mag Bergstrand
Per Gunnar Kjellin
Carl Goeran August Persson
Lars Magnus Soerenby
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of ATA714478A publication Critical patent/ATA714478A/de
Application granted granted Critical
Publication of AT363491B publication Critical patent/AT363491B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
AT0714478A 1977-10-14 1978-10-04 Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen AT363491B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7711581A SE416810C (sv) 1977-10-14 1977-10-14 Forfarande for framstellning av xantinderivat med antiallergisk aktivitet

Publications (2)

Publication Number Publication Date
ATA714478A ATA714478A (de) 1980-09-15
AT363491B true AT363491B (de) 1981-08-10

Family

ID=20332576

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0714478A AT363491B (de) 1977-10-14 1978-10-04 Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen

Country Status (21)

Country Link
US (1) US4233303A (de)
EP (1) EP0001735B1 (de)
JP (1) JPS5479296A (de)
AT (1) AT363491B (de)
AU (1) AU521585B2 (de)
CA (1) CA1109470A (de)
CS (1) CS208756B2 (de)
DD (1) DD139855A5 (de)
DE (1) DE2862017D1 (de)
DK (1) DK148260C (de)
FI (1) FI66383C (de)
HK (1) HK6385A (de)
HU (1) HU180219B (de)
IE (1) IE47884B1 (de)
IT (1) IT1109208B (de)
NO (1) NO147562C (de)
NZ (1) NZ188566A (de)
SE (1) SE416810C (de)
SG (1) SG85584G (de)
SU (1) SU755199A3 (de)
ZA (1) ZA785335B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
AU4527996A (en) * 1994-12-13 1996-07-03 Euro-Celtique S.A. Trisubstituted thioxanthines
EP0814809B1 (de) * 1994-12-13 2003-08-13 Euroceltique S.A. Arylthioxanthine
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) * 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
AR044069A1 (es) 2003-04-25 2005-08-24 Nova Cardia Inc Un metodo de diuresis mejorada en individuos con funcion renal deteriorada
WO2005105083A1 (en) * 2004-04-16 2005-11-10 Novacardia, Inc. Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
CA1077932A (en) 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases

Also Published As

Publication number Publication date
AU521585B2 (en) 1982-04-22
CA1109470A (en) 1981-09-22
FI66383C (fi) 1984-10-10
NO147562B (no) 1983-01-24
DD139855A5 (de) 1980-01-23
AU4036578A (en) 1980-04-17
DK453778A (da) 1979-04-15
EP0001735A1 (de) 1979-05-02
SU755199A3 (en) 1980-08-07
IT1109208B (it) 1985-12-16
SE416810C (sv) 1982-05-11
DK148260C (da) 1986-02-10
FI783126A (fi) 1979-04-15
JPS5479296A (en) 1979-06-25
CS208756B2 (en) 1981-09-15
HK6385A (en) 1985-02-01
EP0001735B1 (de) 1982-09-01
SE7711581L (sv) 1979-04-14
NZ188566A (en) 1984-07-06
ATA714478A (de) 1980-09-15
FI66383B (fi) 1984-06-29
DK148260B (da) 1985-05-20
US4233303A (en) 1980-11-11
IE47884B1 (en) 1984-07-11
SG85584G (en) 1985-06-07
HU180219B (en) 1983-02-28
NO783471L (no) 1979-04-18
DE2862017D1 (en) 1982-10-28
IE782041L (en) 1979-04-14
IT7851499A0 (it) 1978-10-13
NO147562C (no) 1983-05-18
SE416810B (sv) 1981-02-09
ZA785335B (en) 1979-09-26

Similar Documents

Publication Publication Date Title
ATA63678A (de) Verfahren zur herstellung von neuen 1-(1,3dioxolan-2-ylmethyl)-1h-imidazolen und -1h-1,2,4- triaxolen und deren salzen
ATA601078A (de) Verfahren zur herstellung von neuen nitro- imidazolen und von deren salzen
AT363479B (de) Verfahren zur herstellung von neuen imidazo-chinazolinen, deren tautomeren und salzen
AT358023B (de) Verfahren zur herstellung von neuen substi- tuierten 1,1,2-triphenylalken-derivaten und von deren saeureadditionssalzen
AT364851B (de) Verfahren zur herstellung von neuen thienothiazinderivaten und von deren salzen
AT363491B (de) Verfahren zur herstellung von neuen 1,3,8trisubstituierten xanthinen und deren salzen
AT371454B (de) Verfahren zur herstellung von neuen prostanderivaten und von deren salzen
AT366043B (de) Verfahren zur herstellung von neuen chinazolinderivaten und deren salzen
AT355018B (de) Verfahren zur herstellung von neuen 1,2- benzisothiazolinonen und von deren salzen
AT347952B (de) Verfahren zur herstellung von neuen 1,1,1- triarylalkylaminen und deren salzen
AT365188B (de) Verfahren zur herstellung von neuen 7-azabenzimidazolen und deren salzen
AT363937B (de) Verfahren zur herstellung von neuen bispidinderivaten und deren salzen
AT371112B (de) Verfahren zur herstellung von neuen 2-imino-imidazolidin-derivaten und von deren salzen
AT359474B (de) Verfahren zur herstellung von neuen 5-phenoxy- 6,7,8,9-tetrahydro-cyclohepten-7-aminen und von deren saeureadditionssalzen
AT357144B (de) Verfahren zur herstellung von neuen 1-acyl-2- hydroxy-1,3-diaminopropanen und deren salzen
AT367410B (de) Verfahren zur herstellung von neuen 2-benzazepin- verbindungen und deren salzen
AT359070B (de) Verfahren zur herstellung von neuen 2,4-diamino -5-benzylpyrimidinen und deren salzen
AT352139B (de) Verfahren zur herstellung von neuen 2,9- dioxatricyclo-(4,3,1,03,7)decanen und deren salzen
AT360999B (de) Verfahren zur herstellung von neuen amidino- -benzylpyrimidinen und deren salzen
AT358588B (de) Verfahren zur herstellung von neuen 1,2,3,4- -tetrahydroisochinolinen und deren salzen
AT365183B (de) Verfahren zur herstellung von neuen 4-amino-2-piperidinochinazolinderivaten und deren salzen
AT358050B (de) Verfahren zur herstellung von neuen triazolo- thieno-diazepin-1-onen und deren salzen
ATA320578A (de) Verfahren zur herstellung von neuen benzylpyrimidinen und deren salzen
AT361002B (de) Verfahren zur herstellung von neuen 2,9- dioxatricyclo(4,3,1,03,7)decanen und deren salzen
ATA42180A (de) Verfahren zur herstellung von neuen 2,4- -diamino-5-benzylpyrimidinen und deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee